≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Short Achilles tendon (acquired)

EFO MESH Endpoint Browser PheWeb

M13_SHORTACHILLES

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M67.0
  • Cause of death: ICD-10 — M67.0

2 out of 7 registries used, show all original rules.

1060

4. Check minimum number of events

None

1060

5. Include endpoints

None

1060

6. Filter based on genotype QC (FinnGen only)

1060

Control definitions (FinnGen only)

Control exclude
M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M67
Name in latin
Brevitas tendinis calcanei (Achillis) [acquisita]

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7011 5002 1998
Only index persons 6948 4975 1973
Unadjusted period prevalence (%)
Whole population 0.12 0.14 0.06
Only index persons 0.15 0.18 0.08
Median age at first event (years)
Whole population 54.21 56.04 49.69
Only index persons 54.39 56.10 50.08

-FinnGen-

Key figures

All Female Male
Number of individuals 1060 801 259
Unadjusted period prevalence (%) 0.23 0.27 0.11
Median age at first event (years) 55.80 55.82 55.76

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
899
Matched controls
8989
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
1344.5
323.0
387
5
M67.0
ICD-10 Finland
Short Achilles tendon (acquired)
4503599627370496.0
323.0
898
*
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
109.8
269.6
286
38
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
31.2
187.1
254
112
WX702
NOMESCO Finland
Supraglottic ventilation device
20.1
178.6
282
200
M20.1
ICD-10 Finland
Hallux valgus (acquired)
14.4
177.0
327
343
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
9.9
169.5
400
671
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
28.7
148.9
206
92
TPH04
NOMESCO Finland
Cathetrisation of vein
7.2
136.5
412
949
NH3EA
NOMESCO Finland
Feet X-ray examination with load
41.9
134.1
168
49
WX720
NOMESCO Finland
Own respiration
19.0
130.4
207
139
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
19.9
129.5
202
129
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
11.7
123.8
248
284
WX704
NOMESCO Finland
Intubation
9.4
106.2
240
335
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
90.4
100.8
111
14
N03AX12
ATC
gabapentin; oral
7.1
94.6
262
493
WX725
NOMESCO Finland
Noninvasive ventilation
12.1
90.0
173
174
L17
ICPC
Foot/toe symptom/complaint
4.7
89.2
392
1263
M19.0
ICD-10 Finland
Primary arthrosis of other joints
9.2
88.0
198
267
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
39.5
83.0
105
30
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
128.7
77.3
82
7
WX400
NOMESCO Finland
Inhalation anesthesy
10.8
74.1
150
164
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
89.0
73.4
81
10
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
8.3
70.7
168
242
Z01.8
ICD-10 Finland
Other specified special examinations
4.3
69.6
319
1019
ZXA00
NOMESCO Finland
Right side
4.0
69.4
357
1267
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
9.7
67.1
144
174
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.4
64.8
509
2501
ZXD20
NOMESCO Finland
Day surgery
5.0
61.1
225
566
WX214
NOMESCO Finland
Plexus blockade at the ankle
116.6
60.7
65
6
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
12.3
59.9
112
103
WX320
NOMESCO Finland
Spinalanesthesy
3.8
58.6
304
1056
ZXA05
NOMESCO Finland
Left side
3.7
58.4
320
1162
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
27.4
56.6
78
31
SPAT1301
SPAT
No procedures
3.3
55.3
392
1720
M75.1
ICD-10 Finland
Rotator cuff syndrome
4.3
52.4
220
623
N02AJ06
ATC
codeine and paracetamol; systemic
3.0
50.5
405
1907
M79.6
ICD-10 Finland
Pain in limb
3.3
50.4
337
1398
SPAT1263
SPAT
Sampling
2.9
50.3
485
2576
SPAT1324
SPAT
Screening procedure
3.3
50.2
321
1286
SPAT1153
SPAT
Removal of sutures
3.1
49.1
375
1699
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
7.9
48.3
116
166
A02BC03
ATC
lansoprazole; oral
3.0
45.1
339
1497
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.4
42.8
138
291
M01AH05
ATC
etoricoxib; oral
2.7
42.7
587
3708
ZXD10
NOMESCO Finland
Scheduled procedure
0.2
41.7
63
2261
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
25.7
41.5
58
24
M96.0
ICD-10 Finland
Pseudarthrosis after fusion or arthrodesis
80.8
41.3
46
6
M77.4
ICD-10 Finland
Metatarsalgia
8.6
40.5
91
116
M25.5
ICD-10 Finland
Pain in joint
2.9
39.5
309
1376
M79.0
ICD-10 Finland
Rheumatism, unspecified
45.9
39.5
48
11
XX9LA
NOMESCO Finland
Complementary kinetic X-ray examination without contrast
53.7
38.9
46
9
N02AX02
ATC
tramadol; systemic, rectal
2.6
38.6
392
2040
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
5.7
38.0
116
228
R09
ICPC
Sinus symptom/complaint
4.5
36.1
137
342
N02BE01
ATC
paracetamol; systemic, rectal
3.4
35.8
803
6400
Z2221
NOMESCO Finland
Medical doctor
0.2
35.8
29
1539
M67.4
ICD-10 Finland
Ganglion
7.9
34.4
81
111
B01AB05
ATC
enoxaparin; parenteral
2.6
33.5
321
1584
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
14.7
31.5
53
38
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
9.5
30.6
64
72
R44
ICPC
Respiratory, Preventive immunization/medic
14.6
29.7
50
36
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.1
29.4
123
335
TPH07
NOMESCO Finland
Cathetrisation of artery
3.8
29.2
132
385
L16
ICPC
Ankle symptom/complaint
3.9
29.1
131
380
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
6.3
28.8
79
135
SPAT1097
SPAT
Recording of ECG
3.0
27.9
180
686
M48.0
ICD-10 Finland
Spinal stenosis
4.0
27.8
119
330
KMAK
NOMESCO Finland
NA
2.2
27.7
532
3587
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.2
27.5
159
561
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.4
27.2
296
1528
SPAT1202
SPAT
Intra-articular injection
8.3
27.1
61
78
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
42.7
26.9
33
8
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.3
26.7
105
269
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.7
26.1
204
873
M01AE03
ATC
ketoprofen; systemic, rectal
2.2
26.0
356
2045
SAA03
NOMESCO Finland
Extended examination of mouth
2.2
25.8
405
2470
G57.6
ICD-10 Finland
Lesion of plantar nerve
9.3
25.8
54
61
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
4.7
25.6
92
215
SXA05
NOMESCO Finland
NA
18.5
25.4
39
22
WX002
NOMESCO Finland
Sedation and analgesia
2.6
25.4
211
937
L15
ICPC
Knee symptom/complaint
2.6
25.3
221
1009
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.7
25.3
118
352
R74
ICPC
Upper respiratory infection acute
2.3
24.3
298
1611
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
6.3
24.2
66
112
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
7.8
23.7
55
74
L88
ICPC
Rheumatoid/seropositive arthritis
5.7
23.6
70
132
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.2
23.6
136
476
M01AH03
ATC
valdecoxib; oral
4.4
23.4
88
215
S18
ICPC
Laceration/cut
2.1
23.3
384
2360
HAMTE
NOMESCO Finland
NA
17.8
23.3
36
21
-59
ICPC
Other therap proced/minor surg NEC
6.7
23.2
60
95
-1
NOMESCO Finland
NA
2.1
22.8
354
2115
SPAT1081
SPAT
Cardiorespiratory global assessment
4.5
22.8
85
206
N06AA09
ATC
amitriptyline; systemic
3.6
22.5
109
334
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
6.2
22.3
61
104
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.0
22.1
393
2474
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.2
21.9
303
1713
R05
ICPC
Cough
2.3
21.4
234
1185
SPAT1193
SPAT
Pap smear
2.9
21.4
141
538
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.7
21.0
95
275
XQ845
NOMESCO Finland
Dermatoscopy
13.3
20.8
36
28
RF210
NOMESCO Finland
NA
6.4
20.8
55
90
UDC00
NOMESCO Finland
Ear microscopy
3.6
20.6
97
290
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.0
20.6
86
232
N03AX16
ATC
pregabalin; oral
2.4
20.6
202
968
WX100
NOMESCO Finland
Conjunctival surface anesthesia
3.2
20.5
116
400
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
49.2
20.2
24
5
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.0
20.2
127
469
SCC01
NOMESCO Finland
Simple fluorination of mouth or other corresponding procedure
5.5
20.2
61
118
R96
ICPC
Asthma
3.3
20.0
108
359
L08
ICPC
Shoulder symptom/complaint
2.5
20.0
175
788
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
13.0
20.0
35
28
D02
ICPC
Abdominal pain epigastric
4.1
20.0
80
208
M79.7
ICD-10 Finland
Fibromyalgia
11.3
19.8
37
34
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.0
19.8
49
73
XQ848
NOMESCO Finland
Dermatological photography
7.5
19.8
47
66
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.8
19.8
139
550
D07AB02
ATC
hydrocortisone butyrate; topical
2.1
19.8
282
1602
WX892
NOMESCO Finland
Monitored bed care
3.7
19.6
88
253
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.8
19.5
135
530
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
9.9
19.5
39
41
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
3.7
19.4
88
255
M03BX02
ATC
tizanidine; oral
1.9
19.3
556
4120
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
47.1
19.3
23
5
SPAT1044
SPAT
Tympanometry
7.3
19.1
46
66
-31
ICPC
Medical examin/health eval partial
3.4
19.0
95
298
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
10.4
19.0
37
37
J45.9
ICD-10 Finland
Asthma, unspecified
2.5
19.0
169
767
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
3.6
19.0
88
260
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
18.8
144
601
M01AH01
ATC
celecoxib; oral (coxibs)
2.5
18.7
167
757
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
19.2
18.7
28
15
L03
ICPC
Low back symptom/complaint
2.2
18.7
219
1138
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
7.1
18.7
46
68
R4110
NOMESCO Finland
Physiotherapy
0.3
18.5
46
1346
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
15.5
18.5
30
20
AA1AD
NOMESCO Finland
CT of head and brain
2.3
18.5
200
1002
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
3.8
18.4
82
234
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
7.6
18.4
43
59
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
10.1
18.3
36
37
ZXE00
NOMESCO Finland
One hour or less
0.4
18.1
121
2354
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.9
18.1
497
3581
R02
ICPC
Shortness of breath/dyspnoea
2.8
18.1
123
476
NG1DA
NOMESCO Finland
X-ray of knees
8.6
18.1
39
47
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
18.1
111
402
M76.6
ICD-10 Finland
Achilles tendinitis
6.2
18.1
49
83
SDA02
NOMESCO Finland
Parodonthologic therapy
2.0
18.0
325
2013
M67.8
ICD-10 Finland
Other specified disorders of synovium and tendon
53.7
18.0
21
*
R75
ICPC
Sinusitis acute/chronic
4.4
18.0
66
158
J01DB01
ATC
cefalexin; oral
2.1
18.0
728
6037
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
2.9
17.9
119
455
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.8
17.8
123
482
SAA02
NOMESCO Finland
Basic examination of mouth
1.9
17.8
603
4664
A11
ICPC
Chest pain NOS
3.5
17.8
86
263
A02BC05
ATC
esomeprazole; systemic
1.9
17.5
359
2326
SPAT1310
SPAT
Counselling related to known health issue
2.0
17.5
304
1854
R03DC03
ATC
montelukast; oral
2.4
17.2
168
797
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.9
17.0
113
430
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
17.0
211
1119
H02AB06
ATC
prednisolone; systemic
1.9
16.9
390
2626
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
19.7
16.9
25
13
R51.80
ICD-10 Finland
Headache
2.5
16.9
141
615
M01AX01
ATC
nabumetone; oral
4.4
16.8
62
149
R03AC02
ATC
salbutamol; inhalant
1.8
16.7
467
3350
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
16.6
645
5161
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
7.7
16.5
38
51
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
18.3
16.5
25
14
M02AA07
ATC
piroxicam; topical
1.9
16.3
306
1909
M70.6
ICD-10 Finland
Trochanteric bursitis
2.8
16.2
110
426
M01AE01
ATC
ibuprofen; systemic, rectal
2.4
16.2
815
7187
NHK68
NOMESCO Finland
Shortening or lengthening osteotomy of ankle or foot
30.7
16.2
21
7
M54.4
ICD-10 Finland
Lumbago with sciatica
2.5
16.1
142
638
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.8
16.0
111
435
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
6.6
16.0
41
65
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.1
16.0
213
1160
X59
ICD-10 Finland
Exposure to unspecified factor
2.3
15.9
164
796
M19.2
ICD-10 Finland
Other secondary arthrosis
12.5
15.9
28
23
J01MA02
ATC
ciprofloxacin; systemic
1.9
15.9
323
2070
P01BA02
ATC
hydroxychloroquine; oral
3.0
15.8
95
341
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.8
15.6
104
398
D01
ICPC
Abdominal pain/cramps general
2.6
15.6
117
481
NBG10
NOMESCO Finland
Acromioplastia
19.6
15.6
23
12
M01AX05
ATC
glucosamine; oral
2.2
15.5
176
892
M54.5
ICD-10 Finland
Low back pain
1.9
15.5
274
1664
SPAT1254
SPAT
Administration of medicine
2.5
15.4
134
597
D06
ICPC
Abdominal pain localized other
3.0
15.3
92
330
A28
ICPC
Limited function/disability NOS
2.6
15.1
116
482
SPAT1260
SPAT
Consultation of another employee
2.2
14.9
172
876
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
5.2
14.9
46
92
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.0
14.9
243
1431
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
16.8
14.8
23
14
A02BA02
ATC
ranitidine; systemic
2.2
14.8
175
904
I20.99
ICD-10 Finland
Angina pectoris, unspecified
4.0
14.7
59
154
NHL20
NOMESCO Finland
Myotomy or tenotomy of foot
18.8
14.7
22
12
WX402
NOMESCO Finland
General anaesthesia
2.2
14.7
166
839
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
14.7
438
3159
D07AC01
ATC
betamethasone; topical
1.9
14.7
298
1896
M43.1
ICD-10 Finland
Spondylolisthesis
4.8
14.5
48
104
A45
ICPC
General and Unspecified, Observ/health educat/advice/diet
5.5
14.4
42
79
A07EC01
ATC
sulfasalazine; oral, rectal
3.0
14.4
86
306
R01AD09
ATC
mometasone; nasal
1.8
14.3
410
2911
K07.60
ICD-10 Finland
Snapping jaw
3.7
14.2
63
180
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
6.8
14.1
35
53
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.7
14.1
62
176
M01AC06
ATC
meloxicam; systemic, rectal
1.8
14.1
317
2083
SPAT1059
SPAT
Spirometry at the office
3.6
13.9
63
183
WX290
NOMESCO Finland
Other blockade of nerve
1.7
13.9
401
2845
SPAT1058
SPAT
PEF monitoring instruction
2.9
13.8
85
309
WX210
NOMESCO Finland
Plexus blockade of nervus ichiadicus
54.2
13.8
16
*
L84
ICD-10 Finland
Corns and callosities
4.9
13.8
45
96
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
13.8
13.8
23
17
L12
ICPC
Hand/finger symptom/complaint
2.4
13.7
127
584
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.6
13.7
103
424
N06AX21
ATC
duloxetine; oral
2.7
13.7
95
372
NF1DA
NOMESCO Finland
X-ray of hips
6.8
13.7
34
52
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
13.6
195
1090
L14
ICPC
Leg/thigh symptom/complaint
3.1
13.6
77
265
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
4.2
13.5
52
131
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
10.3
13.5
26
26
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
10.3
13.5
26
26
L13
ICPC
Hip symptom/complaint
2.3
13.5
139
671
M20.3
ICD-10 Finland
Other deformity of hallux (acquired)
142.1
13.5
14
*
A02BC01
ATC
omeprazole; systemic
1.9
13.5
229
1362
J01AA02
ATC
doxycycline; systemic
1.8
13.2
681
5709
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
5.4
13.1
39
75
M47.9
ICD-10 Finland
Spondylosis, unspecified
6.1
13.1
35
59
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.3
13.1
67
215
VALMI
NOMESCO Finland
NA
1.9
13.1
246
1516
M01AB05
ATC
diclofenac; systemic, rectal
1.7
13.0
564
4470
WX110
NOMESCO Finland
Local anesthesy
1.7
12.9
605
4900
A01
ICPC
Pain general/multiple sites
3.1
12.9
73
250
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
3.5
12.9
61
184
WX004
NOMESCO Finland
Patient-controlled sedation
14.3
12.8
21
15
L86
ICPC
Back syndrome with radiating pain
3.6
12.7
57
165
X58
ICD-10 Finland
Exposure to other specified factors
2.4
12.7
113
509
L20
ICPC
Joint symptom/complaint NOS
4.3
12.7
47
115
WX213
NOMESCO Finland
Lower leg blockade
15.7
12.7
20
13
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
12.5
173
948
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.7
12.5
493
3785
WX212
NOMESCO Finland
Femoral plexus blockade
9.5
12.5
25
27
L90
ICPC
Osteoarthrosis of knee
3.1
12.5
70
237
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
5.7
12.5
35
63
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.6
12.5
97
404
L34
ICPC
Musculoskeletal, Blood test
131.8
12.5
13
*
L11
ICPC
Wrist symptom/complaint
2.8
12.5
82
312
SPAT1009
SPAT
Measurement of intraocular pressure
7.3
12.4
29
41
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.4
12.3
106
469
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.0
12.3
71
248
NHF25
NOMESCO Finland
Operation for debridement of ankle joint, arthroscopic
9.5
12.0
24
26
S19
ICPC
Skin injury other
4.0
12.0
47
121
Z3231
NOMESCO Finland
Registered nurse
0.4
12.0
63
1359
C07AA05
ATC
propranolol; systemic
2.0
12.0
181
1025
NHG22
NOMESCO Finland
Fusion of subtalar joint
13.6
12.0
20
15
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.0
11.9
157
845
A01AB09
ATC
miconazole; local oral
2.6
11.8
91
380
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.5
11.7
98
427
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
3.4
11.6
55
167
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
5.4
11.6
34
65
WX200
NOMESCO Finland
Interscalenous plexus blockade
8.8
11.6
24
28
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
11.5
286
1910
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
6.5
11.5
29
46
NHL16
NOMESCO Finland
Tenolysis or tenosynovectomy of achilles tendon
121.5
11.4
12
*
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.5
11.3
90
380
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
11.1
348
2479
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
11.1
115
557
K86
ICPC
Hypertension uncomplicated
2.3
10.9
102
470
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.1
10.9
129
662
H25.1
ICD-10 Finland
Senile nuclear cataract
1.9
10.9
171
978
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
10.9
222
1389
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
5.3
10.8
32
62
WVA30
SPAT
NA
4.8
10.8
35
75
M17.5
ICD-10 Finland
Other secondary gonarthrosis
8.1
10.6
23
29
H01
ICPC
Ear pain/earache
2.2
10.6
107
511
L99
ICPC
Musculoskeletal disease other
7.1
10.6
25
36
M20.2
ICD-10 Finland
Hallux rigidus
4.4
10.6
37
86
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.4
10.6
19
17
9271
FHL
Hallux surgery
5.5
10.5
30
56
L04AA13
ATC
leflunomide; oral
4.3
10.4
38
92
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.9
10.4
65
239
N02AJ13
ATC
tramadol and paracetamol; systemic
7.8
10.4
23
30
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
10.4
395
2947
J01EA01
ATC
trimethoprim; systemic
1.8
10.4
225
1433
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.9
10.3
33
70
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.3
10.3
52
166
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
10.3
226
1444
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.4
10.3
87
380
N17
ICPC
Vertigo/dizziness
2.3
10.3
98
456
J02AC01
ATC
fluconazole; systemic
1.6
10.3
374
2756
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
0.4
10.3
58
1225
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.5
10.2
29
54
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.1
10.2
55
185
C01DA14
ATC
isosorbide mononitrate; oral
2.4
10.1
84
366
WX419
NOMESCO Finland
Other general anesthesy
8.6
10.1
21
25
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
11.5
10.1
18
16
RF220
NOMESCO Finland
NA
6.6
10.1
25
39
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.3
10.1
17
607
P06
ICPC
Sleep disturbance
2.3
10.1
94
434
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
10.2
10.0
19
19
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
5.0
10.0
31
64
S06
ICPC
Rash localized
2.9
10.0
59
211
A03FA02
ATC
cisapride; oral, rectal
2.7
9.9
69
271
N39.3
ICD-10 Finland
Stress incontinence
2.5
9.9
79
336
R42
ICD-10 Finland
Dizziness and giddiness
1.9
9.9
163
948
M65.3
ICD-10 Finland
Trigger finger
5.5
9.9
28
52
R03BA05
ATC
fluticasone; inhalant
1.9
9.9
156
893
M01AH02
ATC
rofecoxib; oral
2.2
9.8
99
471
Z97.8
ICD-10 Finland
Presence of other specified devices
26.3
9.8
13
5
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
8.9
9.8
20
23
C10AA03
ATC
pravastatin; oral
3.0
9.8
57
201
WZA00
NOMESCO Finland
Short statement of of health and health related matters
2.8
9.8
61
224
J01DA01
ATC
[U] cefalexin; systemic
1.6
9.8
531
4307
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
9.7
126
669
SPAT1262
SPAT
Handing over of treatment supplies
1.9
9.7
143
799
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.0
9.7
56
196
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.9
9.7
60
219
S01
ICPC
Pain/tenderness of skin
3.5
9.7
44
130
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.9
9.6
142
792
A31
ICPC
General and Unspecified, Medical examin/health eval partial
4.2
9.6
35
85
S04
ICPC
Lump/swelling localized
2.3
9.6
91
422
SFA00
NOMESCO Finland
Small filling
2.0
9.6
125
665
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
11.5
9.6
17
15
P01AB01
ATC
metronidazole; oral, rectal
1.6
9.6
344
2515
M50.3
ICD-10 Finland
Other cervical disc degeneration
5.8
9.6
26
46
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
10.2
9.5
18
18
M09AX01
ATC
hyaluronic acid; parenteral
3.5
9.5
44
132
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
2.3
9.5
85
383
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.6
9.5
349
2567
NDM10
NOMESCO Finland
Palmar fasciotomy of hand
30.4
9.4
12
*
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
30.4
9.4
12
*
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
12.5
9.4
16
13
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
8.2
9.4
20
25
NH3AA
SPAT
NA
4.0
9.3
36
93
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
4.4
9.3
32
74
XF400
NOMESCO Finland
ECG with 12 standard connections
0.3
9.3
19
619
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
7.4
9.2
21
29
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
9.1
187
1167
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
2.1
9.1
103
518
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
9.1
265
1833
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
9.1
317
2294
J04AB02
ATC
rifampicin; systemic
10.2
9.0
17
17
HMAK
NOMESCO Finland
NA
0.3
9.0
19
610
UDM02
NOMESCO Finland
Sinoscopy
4.7
9.0
29
63
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.3
9.0
86
400
M13.9
ICD-10 Finland
Arthritis, unspecified
2.7
8.9
61
239
ZXC35
NOMESCO Finland
Use of radio waves
24.3
8.9
12
5
N06AX11
ATC
mirtazapine; oral
1.6
8.8
258
1780
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.4
8.8
41
933
A78
ICPC
Infectious disease other/NOS
4.5
8.8
30
69
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
8.7
255
1760
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
4.2
8.7
32
79
XF402
NOMESCO Finland
ECG with work load test
2.2
8.7
87
413
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
50.5
8.7
10
*
SPAT1240
SPAT
Therapeutic discussion
2.1
8.7
100
505
A04
ICPC
Weakness/tiredness general
2.1
8.7
102
519
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.5
8.7
39
115
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
8.6
422
3298
R06.0
ICD-10 Finland
Dyspnoea
1.8
8.6
174
1081
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
3.7
8.6
36
100
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
3.7
8.6
36
100
R07
ICPC
Sneezing/nasal congestion
2.6
8.6
62
250
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
11.7
8.6
15
13
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
11.7
8.6
15
13
C09CA01
ATC
losartan; oral
1.7
8.6
187
1186
SPAT1016
SPAT
Examination of vision
3.2
8.6
43
138
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.1
8.6
97
486
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
16.5
8.6
13
8
J01CA04
ATC
amoxicillin; systemic
1.6
8.5
695
6104
J01FA10
ATC
azithromycin; systemic
1.5
8.5
508
4147
S82
ICPC
Naevus/mole
2.0
8.5
113
605
NBL05
NOMESCO Finland
Arthroscopic suture or reinsertation of rotator cuff of shoulder
20.2
8.5
12
6
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.6
8.5
228
1539
B01AC04
ATC
clopidogrel; oral
2.1
8.4
92
455
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
12.9
8.4
14
11
A54
ICPC
General and Unspecified, Repair/fix-suture/cast/prosth device
4.7
8.3
27
59
XF404
NOMESCO Finland
Ambulatory ECG
2.3
8.3
75
341
SPAT1255
SPAT
Intravenous administration of medicine
2.6
8.3
57
224
TNX30
NOMESCO Finland
Soft bandage, unspecified region
7.2
8.3
19
27
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.6
8.2
59
236
N81.6
ICD-10 Finland
Rectocele
2.4
8.2
71
315
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
8.2
129
736
JAETT
NOMESCO Finland
NA
7.6
8.2
18
24
R03BA01
ATC
beclometasone; inhalant
1.9
8.2
116
638
H13
ICPC
Plugged feeling ear
1.8
8.1
137
801
NHG82
NOMESCO Finland
Fusion of other tarsal joint
8.2
8.1
17
21
S08
ICPC
Skin colour change
2.9
8.1
48
173
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
6.9
8.1
19
28
PA7CC
NOMESCO Finland
Very extensive angiography of arteries of neck and brain
33.7
8.1
10
*
M70.8
ICD-10 Finland
Other soft tissue disorders related to use, overuse and pressure
17.4
8.1
12
7
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
9.0
8.1
16
18
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
10.1
8.0
15
15
A06AD11
ATC
lactulose; oral
2.0
8.0
98
510
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
8.0
262
1853
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.0
8.0
30
76
S92.3
ICD-10 Finland
Fracture of metatarsal bone
3.7
7.9
33
92
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
7.9
496
4060
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
4.0
7.9
30
77
HAB40
NOMESCO Finland
Wedge excision of mammary gland
0.1
7.9
5
324
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
13.2
7.9
13
10
PHM99
NOMESCO Finland
Endovenous obliteration of other vein
4.7
7.9
25
54
205
Kela drug reimbursment
Chronic hypertension
1.7
7.9
185
1200
ACC51
NOMESCO Finland
Release of median nerve
2.5
7.8
58
239
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.8
7.8
31
83
M54.6
ICD-10 Finland
Pain in thoracic spine
2.6
7.7
54
215
G44.2
ICD-10 Finland
Tension-type headache
2.0
7.7
107
581
J01CA08
ATC
pivmecillinam; oral
1.5
7.7
368
2836
M01AB16
ATC
aceclofenac; oral
3.7
7.7
32
89
C10AX09
ATC
ezetimibe; oral
2.2
7.7
80
387
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.9
7.7
123
704
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
7.7
329
2475
F29
ICPC
Eye symptom/complaint other
2.2
7.7
75
352
SPAT1251
SPAT
Organisation of medication
3.6
7.6
33
95
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
5.0
7.6
23
47
K08.88
ICD-10 Finland
Other specified disorders of teeth and supporting structures
6.8
7.6
18
27
R52.9
ICD-10 Finland
Pain, unspecified
2.4
7.6
62
268
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
2.1
7.6
88
445
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.0
7.6
97
514
L92
ICPC
Shoulder syndrome
5.2
7.6
22
43
NF3BA
NOMESCO Finland
Femur extensive X-ray examination
25.2
7.6
10
*
M21.5
ICD-10 Finland
Acquired clawhand, clubhand, clawfoot and clubfoot
25.2
7.6
10
*
NHM99
NOMESCO Finland
Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot
25.2
7.6
10
*
DM1CI
NOMESCO Finland
Very extensive cone beam CT of paranasal sinus
25.2
7.6
10
*
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
4.4
7.6
26
61
J01FF01
ATC
clindamycin; systemic
1.6
7.5
205
1382
M79.1
ICD-10 Finland
Myalgia
2.1
7.5
83
415
S09
ICPC
Infected finger/toe
3.7
7.4
31
87
S59
ICPC
Skin, Other therap proced/minor surg NEC
5.3
7.4
21
40
PA7BD
NOMESCO Finland
CT angiography of neck and brain
5.3
7.4
21
40
G03DB02
ATC
megestrol; oral (pregnadien derivatives)
2.8
7.4
47
176
7350A
ICD-9 Finland
Acquired deformities of toe, Hallux valgus (acquired)
4.8
7.4
23
49
ACC19
NOMESCO Finland
Transcision of peripheral nerve: other or unspecified
8.5
7.3
15
18
SPAT1259
SPAT
Opinion on plain films
8.5
7.3
15
18
7261X
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]
+∞
7.3
7
*
S83.2
ICD-10 Finland
Tear of meniscus, current
2.4
7.3
60
261
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
7.3
188
1246
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
3.0
7.2
41
142
L18
ICPC
Muscle pain
3.2
7.2
35
111
WX872
NOMESCO Finland
Intensive care
2.8
7.2
44
163
W19
ICD-10 Finland
Unspecified fall
2.2
7.2
70
331
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
7.2
32
95
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.9
7.2
41
144
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
7.2
62
277
UJF32
NOMESCO Finland
Coloscopy
1.6
7.2
184
1219
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.5
7.2
56
237
M21.0
ICD-10 Finland
Valgus deformity, not elsewhere classified
20.2
7.1
10
5
M01CB01
ATC
sodium aurothiomalate; parenteral
5.1
7.1
21
42
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
6.6
7.1
17
26
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
7.1
64
290
M01AX17
ATC
nimesulide; oral
1.7
7.1
172
1119
A30
ICPC
General and Unspecified, Medical examin/health eval complete
4.6
7.1
23
51
G54.0
ICD-10 Finland
Brachial plexus disorders
4.6
7.1
23
51
M54.2
ICD-10 Finland
Cervicalgia
2.5
7.1
53
220
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.1
7.0
80
403
R03BA08
ATC
ciclesonide; inhalant
2.1
7.0
80
403
NH1AI
NOMESCO Finland
Cone beam CT of ankle
10.1
7.0
13
13
R21
ICPC
Throat symptom/complaint
1.7
7.0
167
1084
K76
ICPC
Ischaemic heart dis without angina
4.0
7.0
26
66
G04BD12
ATC
mirabegron; oral
2.1
7.0
78
391
K02.1
ICD-10 Finland
Caries of dentine
1.5
7.0
473
3891
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.5
7.0
50
203
N05CF01
ATC
zopiclone; oral
1.5
7.0
242
1726
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.8
6.9
44
164
A29
ICPC
General symptom/complaint other
2.0
6.9
86
451
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
6.9
125
745
SALPR
NOMESCO Finland
NA
13.9
6.9
11
8
VALPR
NOMESCO Finland
NA
13.9
6.9
11
8
SP000
NOMESCO Finland
NA
13.9
6.9
11
8
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
2.6
6.9
46
180
SPAT1285
SPAT
Provision of consultation response
2.6
6.9
48
191
K07
ICPC
Swollen ankles/oedema
3.3
6.9
33
104
NH1AD
NOMESCO Finland
Ankle and foot CT
4.4
6.9
23
53
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.8
199
1359
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
3.7
6.8
28
78
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
6.8
107
612
NGM10
NOMESCO Finland
Fasciotomy of of knee or lower leg
16.8
6.8
10
6
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.6
6.7
47
187
NDG20
NOMESCO Finland
Fusion of wrist, partial
22.7
6.7
9
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
6.7
75
376
P20
ICPC
Memory disturbance
2.1
6.7
73
363
S29
ICPC
Skin symptom/complaint other
1.7
6.7
128
780
-44
ICPC
Preventive immunization/medic
2.1
6.6
71
351
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
6.0
6.6
17
29
N03
ICPC
Pain face
7.9
6.6
14
18
L19
ICPC
Muscle symptom/complaint NOS
4.1
6.6
24
60
R99
ICPC
Respiratory disease other
4.6
6.6
21
46
ZZH22
NOMESCO Finland
Graft of patients own bone, block
12.4
6.6
11
9
NBL22
NOMESCO Finland
Myotomy, tenotomy or excision of tendon of upper arm
12.4
6.6
11
9
M84.0
ICD-10 Finland
Malunion of fracture
12.4
6.6
11
9
U05
ICPC
Urination problems other
2.9
6.5
38
136
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
4.2
6.5
23
56
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.6
6.5
27
76
L84
ICPC
Back syndrome without radiat pain
2.9
6.5
37
130
M22.4
ICD-10 Finland
Chondromalacia patellae
3.3
6.4
30
93
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
70.3
6.4
7
*
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
70.3
6.4
7
*
SPAT1050
SPAT
Extensive neurological examination
4.1
6.4
23
57
FM1BD
NOMESCO Finland
Extensive CT of heart
14.4
6.4
10
7
G01AF04
ATC
miconazole; vaginal
2.3
6.4
55
247
R08
ICPC
Nose symptom/complaint other
3.1
6.4
32
105
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
6.3
176
1187
L01
ICPC
Neck symptom/complaint
1.8
6.3
102
589
K04.0
ICD-10 Finland
Pulpitis
2.0
6.3
81
430
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
6.3
54
242
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
3.0
6.3
33
112
UKC02
NOMESCO Finland
Cystoscopy
1.9
6.3
94
529
1302
NOMESCO Finland
NA
+∞
6.3
6
*
NGW10
NOMESCO Finland
Reoperation for deep infection in in surgery of knee or lower leg
+∞
6.3
6
*
XQ832
NOMESCO Finland
Other provocation test
+∞
6.3
6
*
EGA05
NOMESCO Finland
Rinsing of mandipular joint
+∞
6.3
6
*
A03
ICPC
Fever
1.7
6.3
134
844
G47.9
ICD-10 Finland
Sleep disorder, unspecified
3.8
6.2
24
64
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
6.2
54
244
DJD20
NOMESCO Finland
Plastic repair of septum of nose
3.0
6.2
33
113
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
6.3
6.2
15
24
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
5.8
6.2
16
28
SPAT1325
SPAT
Vaccination
1.5
6.1
248
1824
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
0.3
6.1
9
346
M01AC01
ATC
piroxicam; systemic, rectal
1.8
6.1
96
546
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.9
6.1
18
37
A02BX02
ATC
sucralfate; oral
2.9
6.1
35
125
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
2.5
6.0
43
174
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
6.0
141
908
S56
ICPC
Skin, Dressing/pressure/compress/tamponade
10.1
6.0
11
11
J01XX08
ATC
linezolid; systemic
10.1
6.0
11
11
S96.8
ICD-10 Finland
Injury of other muscles and tendons at ankle and foot level
10.1
6.0
11
11
RTGHF
NOMESCO Finland
NA
10.1
6.0
11
11
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
3.6
6.0
25
71
M01AE51
ATC
ibuprofen, combinations; systemic
5.2
6.0
17
33
R07.3
ICD-10 Finland
Other chest pain
2.1
6.0
62
302
A59
ICPC
General and Unspecified, Other therap proced/minor surg NEC
6.1
6.0
15
25
R01AD08
ATC
fluticasone; nasal
1.5
6.0
225
1630
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
0.1
6.0
*
203
EB1AA
SPAT
NA
0.1
6.0
*
203
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.9
6.0
81
440

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3047181) Lactate [Moles/volume] in Blood
229
233
12.26
207.56
6.3
8.6
mmol/l
1.2
1.3
0.60
211
205
(3018572) Chloride [Moles/volume] in Blood
182
164
13.19
177.75
6.9
10.6
mmol/l
104.9
105.3
0.37
170
150
(3039000) Anion gap in Blood
182
164
13.19
177.75
6.9
10.6
mmol/l
10.9
11.5
1.13
170
150
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
293
549
6.99
158.39
3.5
2.8
ng/l
107.3
173.7
2.89
284
488
(3007930) Methemoglobin/Hemoglobin.total in Blood
199
280
8.52
138.85
6.6
7.5
%
1.1
0.9
5.41
187
262
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
197
284
8.29
134.47
6.7
7.4
%
1.8
1.6
3.48
185
267
(3008152) Bicarbonate [Moles/volume] in Arterial blood
227
416
6.67
123.60
7.3
7.8
mmol/l
24.8
24.7
0.20
208
386
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
204
370
6.59
111.69
7.0
10.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
396
1396
3.93
95.14
4.1
3.2
ng/l
89.1
348.5
2.66
287
1001
(3019150) Specific gravity of Urine by Refractometry
434
1686
3.67
89.22
3.8
3.6
kg/l
1.0
1.0
0.16
86
255
(3019060) Gas panel - Arterial blood
198
435
5.37
87.37
6.9
5.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
575
2787
3.32
80.76
4.3
3.0
u/l
30.3
31.7
0.20
553
2660
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
561
8338
0.30
77.75
10.9
10.4
ml/min/173m2
86.5
82.9
2.84
321
6737
(3032080) INR in Blood by Coagulation assay
571
2896
3.11
71.66
8.8
7.3
inr
1.2
1.2
0.32
81
855
(3002173) Hemoglobin [Mass/volume] in Arterial blood
222
649
4.06
67.37
6.9
8.2
g/l
125.1
121.7
1.61
203
622
(3016502) Oxygen saturation in Arterial blood
217
671
3.81
60.36
6.9
8.1
%
97.3
95.8
4.96
204
644
(3003396) Base excess in Arterial blood by calculation
233
776
3.57
57.80
6.9
7.5
mmol/l
2.2
1.2
4.61
173
623
(3002385) Erythrocyte distribution width [Ratio]
989
7497
5.77
54.88
20.8
13.8
%
13.5
13.6
1.65
977
7308
(3027801) Oxygen [Partial pressure] in Arterial blood
226
771
3.45
53.71
7.0
7.6
kpa
12.0
12.5
1.26
213
736
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
226
771
3.45
53.71
7.0
7.6
kpa
5.0
5.1
1.82
213
736
(3024561) Albumin [Mass/volume] in Serum or Plasma
586
3347
2.68
53.68
6.9
4.5
g/l
35.7
36.1
0.92
556
3122
(3021589) Normoblasts [#/volume] in Blood
125
3706
0.25
51.98
8.8
8.1
e9/l
0.0
0.0
0.07
106
3035
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
111
259
4.67
44.58
1.1
1.1
u/ml
19.1
6.3
—
5
33
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
450
2425
2.49
44.18
3.0
2.3
u/l
53.4
59.8
2.85
440
2233
(3013707) Erythrocyte sedimentation rate by Westergren method
844
6166
2.81
41.21
6.1
3.5
mm/h
11.1
11.7
0.81
827
5689
(3037467) Urinalysis macro (dipstick) panel - Urine
788
5611
2.58
39.76
6.3
3.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
80
161
5.29
38.14
4.6
3.3
mg/l
19.7
24.4
0.59
65
101
(3042936) Bacteria identified in Isolate by Culture
232
970
2.78
37.62
2.4
1.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
419
2324
2.33
37.04
2.1
1.6
mmol/l
1.4
1.4
0.10
405
1965
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
282
1320
2.55
36.30
1.3
1.2
u/ml
16.6
13.7
0.18
71
529
(3013826) Glucose [Moles/volume] in Serum or Plasma
662
4548
2.21
33.36
6.0
4.1
mmol/l
6.5
6.6
0.34
608
4207
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
184
736
2.82
32.10
1.9
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
37
1877
0.17
31.78
2.2
2.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
282
1395
2.39
31.65
1.3
1.2
iu/ml
22.1
30.6
1.16
150
469
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
574
3785
2.13
31.41
5.7
3.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
182
732
2.79
31.38
2.0
1.7
—
—
—
0
0
(3013512) EKG study
62
2181
0.24
30.17
3.6
3.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
571
3803
2.09
29.89
8.8
6.3
mmol/l
1.2
1.2
0.15
504
3207
(3026008) Bacteria identified in Urine by Culture
401
2379
2.10
28.25
3.7
2.6
—
—
—
0
0
(3044889) 12 lead EKG panel
789
6051
2.19
26.96
4.0
3.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
62
2025
0.26
25.95
2.3
2.6
e6/l
0.2
0.5
2.87
44
1469
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
820
6426
2.22
25.89
7.9
7.0
u/l
74.8
77.9
1.82
806
6044
(3018418) pH of Serum or Plasma
379
2260
2.05
25.85
3.1
3.6
ph
7.4
7.4
0.15
12
408
(3012516) Albumin [Mass/volume] in Urine
368
2188
2.04
25.17
2.9
3.2
mg/l
2908.8
405.3
2.80
194
1315
(3041096) Erythrocytes [Presence] in Urine by Automated
375
2248
2.03
25.04
3.5
2.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
160
676
2.61
24.73
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
388
2371
2.00
24.42
2.8
3.1
mmol/l
6.8
7.4
2.32
371
2014
(3031040) Bacteria [#/volume] in Urine by Automated count
704
5293
1.98
23.72
5.5
3.8
e6/l
362.9
1666.3
1.11
57
71
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
345
2083
1.97
22.03
2.1
2.0
u/l
146.0
246.1
1.35
327
1961
(3019550) Sodium [Moles/volume] in Serum or Plasma
1013
8961
3.94
21.47
18.5
12.5
mmol/l
139.8
139.8
0.01
1008
8715
(3020682) Albumin/Creatinine [Ratio] in Urine
372
2323
1.93
21.38
2.9
3.8
mg/mmol
10.7
8.3
0.27
200
1412
(3017704) Immunofixation for Urine
32
46
7.14
21.29
1.2
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1013
8990
3.86
20.74
18.8
12.6
mmol/l
4.0
3.9
2.15
1008
8723
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
457
3086
1.85
20.32
4.0
3.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
837
6851
2.05
20.07
4.7
4.0
pmol/l
14.6
14.7
0.23
815
6245
(40761511) CBC panel - Blood by Automated count
1029
9257
4.82
19.99
20.6
10.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
1241
0.18
19.76
1.9
2.4
e6/l
0.2
1.2
9.83
14
664
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
1172
0.17
19.22
2.0
2.5
e6/l
3.2
3.4
0.04
11
598
(3040151) Glucose [Moles/volume] in Capillary blood
37
69
5.52
19.12
6.3
3.6
mmol/l
11.0
7.8
0.39
29
58
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
39
1417
0.25
18.84
1.8
2.9
mmol/l
2.4
2.5
1.66
34
1256
(40758558) Short blood count panel - Blood
89
2096
0.37
18.68
3.7
6.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
81
1986
0.36
18.55
2.0
2.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
957
8342
2.51
18.29
21.8
12.2
%
38.4
39.8
2.53
504
6296
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
983
8685
2.81
18.12
16.4
11.1
mg/l
19.3
22.5
2.73
832
6624
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
484
3412
1.77
17.99
5.9
5.3
mmol/l
1.2
1.2
1.22
452
3091
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
274
1625
1.93
17.86
1.7
1.6
pmol/l
58077313.7
29853371.9
0.29
260
1360
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
936
8114
2.31
17.54
5.7
4.6
mu/l
1.9
2.1
0.58
920
7436
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
89
331
2.84
17.47
2.1
1.9
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
19
18
10.73
17.36
3.0
1.9
%
8.1
11.2
0.38
14
18
(3010144) Erythrocytes [#/volume] in Synovial fluid
33
61
5.55
17.21
1.7
1.4
e6/l
95444.7
4566.2
0.67
17
41
(3023368) Bacteria identified in Blood by Culture
294
1806
1.87
17.10
3.6
3.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
43
101
4.40
17.02
1.6
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
31
55
5.78
16.87
1.3
1.3
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
19
19
10.16
16.74
3.0
1.9
%
24.3
24.9
0.06
14
19
(4010399)
125
564
2.38
16.54
1.4
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
560
4198
1.71
16.06
5.6
6.1
umol/l
10.4
11.0
1.05
544
3984
(3026361) Erythrocytes [#/volume] in Blood
1052
9993
7.99
15.93
24.5
16.6
e12/l
4.5
4.5
0.34
1047
9686
(3010813) Leukocytes [#/volume] in Blood
1052
9997
7.93
15.75
24.5
16.7
e9/l
6.7
6.6
0.67
1047
9686
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
54
162
3.46
15.23
1.9
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
138
674
2.20
15.12
2.1
2.0
nmol/l
406.7
383.3
0.62
129
616
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
62
205
3.15
14.97
3.6
2.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
530
3969
1.67
14.81
3.8
3.2
estimate
0.0
0.0
0.00
27
682
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
192
1069
1.97
14.81
2.0
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
267
1664
1.81
14.49
1.6
1.4
nmol/l
22.2
21.3
0.48
259
1425
(3019069) Monocytes/100 leukocytes in Blood
513
3840
1.65
14.13
7.1
5.7
%
8.2
8.5
1.47
498
3597
(3006504) Eosinophils/100 leukocytes in Blood
510
3820
1.65
13.95
6.5
5.4
%
3.0
2.8
1.01
494
3557
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
471
3467
1.65
13.74
2.6
2.2
nmol/l
76.3
77.3
0.31
450
3141
(3037522) Nuclear Ab [Titer] in Serum
186
1050
1.94
13.71
1.5
1.3
titre
503.6
590.3
0.24
39
203
(3007853) Bacteria identified in Skin by Aerobe culture
153
809
2.04
13.58
2.0
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
374
2602
1.68
13.55
5.7
5.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
486
3616
1.64
13.51
3.0
2.6
ug/l
100.2
113.1
0.69
480
3358
(3008898) HLA-B27 [Presence]
73
282
2.71
13.34
1.1
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
517
3923
1.62
13.15
6.7
5.3
%
55.5
56.5
1.23
504
3677
(3009261) Glucose [Presence] in Urine by Test strip
529
4046
1.61
12.96
3.9
3.2
estimate
0.0
0.0
0.50
24
674
(4035726)
14
785
0.17
12.91
1.4
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
39
105
3.82
12.90
1.9
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
522
3989
1.61
12.76
6.5
5.4
%
29.8
28.9
1.00
509
3728
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1023
9473
3.29
12.68
12.3
9.2
u/l
26.8
25.9
0.92
1016
9134
(3018677) aPTT in Platelet poor plasma by Coagulation assay
187
1085
1.88
12.61
1.6
1.8
s
27.2
29.3
2.87
171
1045
(3019225) pH of Specimen
12
738
0.15
12.58
3.2
4.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
161
2676
0.53
12.34
4.0
3.2
e6/l
117.4
115.1
0.01
126
1789
(3044640) Blood type and Crossmatch panel - Blood
148
2524
0.52
12.34
2.1
2.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
29
65
4.56
12.18
1.4
1.6
%
47.2
55.9
0.44
20
46
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
169
959
1.91
12.18
1.4
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
904
7991
1.89
12.17
6.0
5.0
mmol/mol
38.9
39.0
0.09
891
7425
(3022096) Basophils/100 leukocytes in Blood
489
3707
1.59
12.17
6.3
5.5
%
0.7
0.7
0.19
471
3450
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
949
8548
2.05
11.76
4.6
4.1
mmol/l
5.7
5.8
1.11
935
7825
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
709
5891
1.61
11.75
3.5
2.8
u/l
48.5
45.6
0.47
692
5518
(3021601) Nitrite [Presence] in Urine by Test strip
518
4004
1.57
11.70
5.5
4.5
estimate
0.0
0.0
0.50
28
697
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
906
0.26
11.68
9.3
5.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
14
15
9.44
11.67
1.8
4.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
280
1871
1.67
11.51
1.3
1.2
u/ml
3.4
1.8
0.36
63
471
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
24
48
5.09
11.51
3.3
1.9
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
106
523
2.14
11.25
1.5
1.2
u/ml
142.0
208.7
0.54
97
479
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
270
1805
1.67
11.01
2.4
2.0
mg/l
1.9
2.9
25.26
261
1523
(3000475) Leukocytes [#/volume] in Synovial fluid
46
154
3.08
10.91
1.6
1.6
e6/l
21108.3
12505.9
0.23
40
115
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
51
4.79
10.75
3.3
1.9
%
18.3
13.6
0.59
14
18
(3052592) Norovirus Ag [Presence] in Stool
16
9
18.03
10.74
1.1
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
67
1407
0.44
9.94
2.6
2.4
mosm/kgh2o
466.4
540.3
2.14
56
1189
(3023419) Bacteria identified in Sputum by Culture
30
81
3.78
9.92
2.8
2.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
527
4192
1.51
9.81
6.1
5.7
e9/l
0.2
0.2
1.16
513
3697
(40768804) Tissue Pathology biopsy report
250
3518
0.62
9.64
1.9
2.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
12
14
8.66
9.36
4.2
5.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
152
905
1.79
9.29
1.7
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
44
158
2.86
9.26
1.4
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
35
110
3.26
9.24
1.5
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
11
12
9.25
8.99
3.8
5.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
21
6.74
8.91
1.6
2.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
21
6.74
8.91
1.6
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
973
8994
2.00
8.90
5.4
4.5
mmol/l
2.8
2.9
1.30
957
8345
(3023323) Follitropin [Units/volume] in Serum or Plasma
91
464
2.05
8.86
1.4
1.3
iu/l
26.7
34.7
1.63
86
400
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
77
369
2.17
8.81
2.6
2.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
44
163
2.77
8.76
1.2
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
12
573
0.20
8.71
8.3
7.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
239
1642
1.59
8.47
1.8
1.5
mg/l
0.9
1.1
0.22
200
1219
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
960
8864
1.88
8.37
4.7
4.1
mmol/l
4.9
4.8
0.56
951
8281
(40761535) Cells panel - Urine sediment
11
540
0.20
8.33
2.9
3.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
96
515
1.95
8.12
2.9
2.7
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
10
11
9.17
8.09
4.1
4.9
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
11
9.17
8.09
1.2
1.4
—
—
—
0
0
(3001729) Color of Synovial fluid
11
5
22.21
8.02
2.2
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
175
1131
1.66
7.91
5.6
4.0
%
20.3
20.9
0.19
59
484
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
106
595
1.87
7.82
3.4
3.6
ng/l
79.9
84.5
0.21
99
523
(3011412) CD3 cells [#/volume] in Blood
24
66
3.70
7.77
3.3
2.2
e9/l
1.4
1.1
0.21
19
43
(3032773) Endomysium IgG Ab [Titer] in Serum
26
76
3.48
7.70
1.1
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
44
4.38
7.70
3.1
2.2
%
43.6
40.9
0.18
13
12
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
395
3073
1.45
7.63
2.0
1.8
pmol/l
101.2
97.5
0.85
181
1540
(3001604) Monocytes [#/volume] in Blood
496
4029
1.43
7.57
6.0
5.4
e9/l
0.6
0.6
1.12
478
3496
(3002582) Erythrocytes [#/volume] in Urine
145
2219
0.60
7.57
3.4
2.7
e6/l
59.5
92.0
0.32
117
1656
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
952
8818
1.78
7.51
4.4
4.1
mmol/l
1.5
1.5
0.36
942
8187
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
7
350
0.19
7.46
8.0
8.6
mmol/l
23.9
24.5
—
7
334
(40761536) Microorganisms panel - Urine sediment
22
668
0.32
7.40
2.8
3.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
267
1934
1.51
7.34
2.4
2.4
umol/l
331.7
7505.3
7.99
253
1691
(3019198) Lymphocytes [#/volume] in Blood
509
4170
1.42
7.33
6.1
5.4
e9/l
2.0
1.9
0.35
492
3691
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
85
455
1.94
7.24
1.8
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
187
1255
1.60
7.23
1.5
1.7
nmol/l
1111.1
1153.3
0.37
174
928
(3006315) Basophils [#/volume] in Blood
495
4045
1.42
7.18
6.1
5.4
e9/l
0.0
0.0
0.09
483
3509
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
184
2630
0.64
7.10
2.7
2.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
39
152
2.63
7.09
1.7
2.0
g/l
130.7
133.8
0.38
34
113
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
222
1571
1.52
6.76
1.6
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
148
953
1.64
6.75
2.4
2.3
%
23.8
23.7
0.02
49
816
(44790048)
25
78
3.26
6.73
1.5
1.6
—
—
—
0
0
(44790047)
25
78
3.26
6.73
1.5
1.6
—
—
—
0
0
(44790049)
25
78
3.26
6.73
1.5
1.6
—
—
—
0
0
(44806118)
25
78
3.26
6.73
1.5
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
285
0.17
6.60
2.4
2.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
10
15
6.72
6.32
1.4
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
666
5801
1.40
6.31
3.3
3.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
49
226
2.22
6.22
1.5
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
63
1135
0.53
5.84
1.2
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
39
168
2.37
5.80
1.5
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
259
0.19
5.66
1.2
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
32
127
2.57
5.66
1.3
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
261
0.19
5.65
2.4
1.9
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
13
29
4.53
5.52
1.0
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
62
328
1.95
5.51
3.7
3.2
mmol/l
26.7
25.4
1.03
52
320
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
38
3.99
5.45
1.0
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
37
163
2.32
5.26
1.9
1.2
u/ml
93.6
38.9
—
5
17
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
26
98
2.69
5.10
1.8
1.3
pmol/l
437.6
305.7
0.93
21
81
(3013650) Neutrophils [#/volume] in Blood by Automated count
558
4825
1.33
4.97
7.7
8.9
e9/l
4.1
4.0
0.47
544
4220
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
123
0.00
4.94
0.0
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
17
51
3.37
4.90
1.4
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
28
4.32
4.83
2.1
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
28
113
2.52
4.82
1.4
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
37
3.82
4.82
1.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
239
1824
1.40
4.77
1.4
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
92
575
1.66
4.73
2.8
2.9
g/l
10.7
10.5
0.10
81
522
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
264
0.26
4.62
1.0
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
29
624
0.45
4.54
5.4
4.1
%
0.0
0.2
4.96
12
158
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
40
767
0.50
4.52
2.3
2.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
12
30
4.03
4.44
2.5
4.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
50
270
1.89
4.24
2.4
2.0
u/l
2222.1
1160.5
0.29
21
118
(3017143) Hepatitis C virus Ab [Presence] in Serum
133
933
1.49
4.16
1.5
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
103
0.00
4.04
0.0
1.0
—
—
—
0
0
(3020891) Body temperature
7
244
0.28
3.89
16.4
3.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
127
2.24
3.79
1.4
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
385
0.38
3.65
1.1
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
56
330
1.74
3.62
1.7
2.0
u/l
37.7
39.3
0.35
50
298
(4034850)
9
266
0.33
3.58
9.8
7.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
34
611
0.54
3.17
3.8
3.8
%
0.2
0.7
—
5
131
(3014133) Dog dander IgE Ab [Units/volume] in Serum
24
111
2.19
3.14
1.0
1.0
u/ml
0.7
3.9
1.43
14
39
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
98
2.27
3.14
1.0
1.1
u/ml
1.4
2.7
0.66
12
37
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
214
0.32
3.08
1.4
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
215
0.32
3.07
2.6
3.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
8
7.53
3.05
12.8
4.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
26
126
2.09
3.04
1.1
1.1
u/ml
2.7
6.4
0.69
12
55
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
51
2.77
2.99
3.9
6.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
20
418
0.47
2.97
7.3
7.8
%
1.2
1.4
0.50
20
413
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
77
0.00
2.97
0.0
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
92
644
1.47
2.95
1.3
1.3
iu/ml
108.7
138.0
0.40
50
258
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
7
209
0.33
2.95
5.9
2.4
g/l
3.9
1.4
—
7
185
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
224
0.35
2.94
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
223
0.35
2.94
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
227
0.35
2.93
1.0
1.1
—
—
—
0
0
(4027681)
13
46
2.85
2.92
1.2
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
12
305
0.39
2.91
4.3
2.3
%
0.7
0.7
0.04
12
296
(3011397) Hemoglobin [Presence] in Urine by Test strip
137
1783
0.73
2.89
4.0
3.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
109
1469
0.71
2.86
3.4
2.3
e6/l
5.0
7.3
1.33
104
1273
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
74
0.00
2.78
0.0
1.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
25
125
2.02
2.72
1.4
1.3
mmol/l
6.1
7.2
1.72
17
82
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
146
1.94
2.72
1.3
1.1
u/ml
1.1
3.4
0.77
13
53
(3010726) Horse dander IgE Ab [Units/volume] in Serum
24
119
2.04
2.67
1.1
1.1
u/ml
0.5
3.4
1.71
14
30
(3004451) EKG impression Narrative
9
24
3.77
2.67
1.0
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
8
210
0.38
2.56
2.0
2.7
mg/l
1.4
1.5
—
8
196
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
44
2.75
2.55
1.1
1.1
u/l
1.0
1.1
—
5
26
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
37
216
1.74
2.55
1.9
1.2
—
57.9
—
0
20
(3048689) Calprotectin [Mass/mass] in Stool
131
1003
1.35
2.54
2.6
2.2
ug/g
111.4
118.2
0.10
120
796
(3008401) Mugwort IgE Ab [Units/volume] in Serum
24
122
1.99
2.52
1.0
1.1
u/ml
0.4
1.1
—
10
45
(3006653) Thiamine [Moles/volume] in Blood
11
39
2.84
2.48
1.7
1.2
nmol/l
137.0
144.2
0.16
11
39
(3000330) Specific gravity of Urine by Test strip
20
389
0.50
2.46
4.1
3.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
66
0.00
2.41
0.0
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
66
0.00
2.41
0.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
66
0.00
2.41
0.0
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
28
153
1.85
2.40
1.1
1.3
—
—
—
0
0
(4146454)
0
67
0.00
2.39
0.0
2.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
68
962
0.69
2.36
1.6
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
67
950
0.69
2.36
1.5
2.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
16
71
2.27
2.35
3.8
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
37
593
0.61
2.32
4.6
4.1
%
0.0
0.7
0.63
14
132
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
45
286
1.60
2.28
1.4
1.3
miu/ml
142.3
245.4
1.22
13
137
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
59
0.00
2.25
0.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
60
0.00
2.25
0.0
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
67
2.26
2.18
1.1
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
16
74
2.18
2.15
3.5
4.9
u/ml
486.6
38.9
—
5
26
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
43
652
0.65
2.13
1.3
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
18
343
0.52
2.11
1.3
1.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
10
235
0.42
2.09
2.2
4.1
mmol/l
24.7
25.0
—
10
221
(3051651) Icteric interference index of Serum or Plasma
0
55
0.00
2.07
0.0
3.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
55
0.00
2.07
0.0
1.6
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
58
0.00
2.04
0.0
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
58
0.00
2.04
0.0
1.1
—
80.0
—
0
9
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
114
888
1.32
2.00
1.5
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
116
906
1.31
2.00
2.8
2.3
umol/l
8.2
7.3
0.19
104
779
(3035637) Corticotropin [Mass/volume] in Plasma
16
78
2.07
1.91
2.3
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
50
0.00
1.89
0.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
22
3.20
1.88
1.7
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
52
2.32
1.88
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
35
2.58
1.80
4.8
3.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
23
3.06
1.80
1.6
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
7
23
3.06
1.80
2.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
167
0.42
1.79
2.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
61
832
0.72
1.77
2.1
2.8
ug/l
0.8
0.8
0.10
23
513
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
16
297
0.53
1.76
4.7
3.5
%
48.1
49.0
0.05
16
292
(3044927) Protein electrophoresis panel - Urine
14
67
2.10
1.76
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
37
241
1.55
1.75
1.3
1.6
—
0.1
—
0
38
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
132
1.76
1.74
1.2
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
48
0.00
1.70
0.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
24
144
1.68
1.58
1.4
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
310
2761
1.17
1.58
3.1
2.9
ng/l
38.6
32.6
0.20
141
1688
(3014576) Chloride [Moles/volume] in Serum or Plasma
63
836
0.74
1.56
4.7
6.0
mmol/l
103.2
104.2
0.60
46
812
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
71
1.98
1.54
1.4
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
55
400
1.40
1.54
2.3
1.9
nmol/l
12.1
12.9
0.29
47
354
(40768797) Stomach Pathology biopsy report
134
1105
1.24
1.53
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
108
1.77
1.51
1.4
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
58
2.08
1.49
1.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
48
660
0.71
1.49
3.8
4.0
%
0.2
1.0
2.50
13
178
(3012095) Magnesium [Moles/volume] in Serum or Plasma
141
1174
1.23
1.48
2.6
3.3
mmol/l
0.8
0.8
0.84
135
1107
(3036489) Thrombin time
17
291
0.58
1.46
2.0
1.6
s
29.4
21.0
0.42
12
257
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
65
848
0.75
1.45
1.5
2.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
10
201
0.49
1.44
3.3
3.6
u/ml
32.6
34.0
—
10
196
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
42
295
1.44
1.44
2.4
3.4
u/ml
27.0
826.2
0.93
33
262
(3013139) Helicobacter pylori Ag [Presence] in Stool
70
537
1.33
1.42
1.1
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
25
157
1.61
1.41
1.4
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
27
173
1.58
1.41
1.4
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
148
1246
1.22
1.41
1.5
1.6
—
—
—
0
0
(3000492) Spirometry study
61
799
0.75
1.40
1.3
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
22
134
1.66
1.40
1.4
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
0
37
0.00
1.34
0.0
2.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
39
0.00
1.34
0.0
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
17
283
0.59
1.33
2.2
3.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
40
0.00
1.33
0.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
40
0.00
1.33
0.0
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
40
0.00
1.33
0.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
40
0.00
1.33
0.0
1.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
25
378
0.65
1.31
2.0
1.7
mg/l
6.5
5.1
0.16
14
254
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
99
1.73
1.27
1.4
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
15
84
1.80
1.27
1.0
1.0
u/ml
0.0
0.5
—
5
20
(3029937) Albumin [Presence] in Urine by Test strip
229
2031
1.16
1.22
4.4
3.5
estimate
0.0
0.0
0.80
25
680
(1761482) Bacteria [#/volume] in Urine by Culture
11
201
0.54
1.22
4.2
3.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
78
1.81
1.21
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
164
1.54
1.21
1.6
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
213
0.56
1.20
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
94
1.71
1.18
1.1
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
127
0.47
1.17
1.2
2.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
20
2.51
1.15
3.6
5.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
222
0.58
1.15
1.1
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
51
1.97
1.11
1.3
1.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
21
2.39
1.09
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
169
1.49
1.08
1.5
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
23
153
1.51
1.07
1.7
1.7
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
33
2.13
1.05
1.4
1.2
—
1.5
—
0
6
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
28
394
0.70
1.05
2.5
3.6
kpa
5.1
5.2
0.34
28
373
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
124
0.48
1.05
1.2
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
26
179
1.46
1.03
1.3
1.3
mg/l
446.2
482.9
0.26
21
170
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
151
0.53
1.03
2.0
3.2
%
58.8
56.0
—
8
151
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
139
1.52
1.00
1.5
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
198
1.43
0.98
5.8
2.5
u/ml
0.3
0.4
0.87
23
111
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
22
148
1.50
0.98
3.8
5.7
iu/ml
117.8
234.0
—
6
21
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
29
0.00
0.98
0.0
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
207
1854
1.14
0.97
2.5
2.8
ng/l
776.2
1060.2
1.10
191
1523
(3019832) Treponema pallidum Ab [Presence] in Serum
64
789
0.80
0.97
1.6
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
30
0.00
0.97
0.0
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
30
0.00
0.97
0.0
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
30
0.00
0.97
0.0
2.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
23
157
1.48
0.96
2.1
4.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
46
589
0.77
0.95
1.5
1.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
32
0.00
0.95
0.0
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
32
0.00
0.95
0.0
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
32
0.00
0.95
0.0
7.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
143
0.56
0.93
2.0
3.0
e9/l
3.9
4.0
—
8
143
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
209
1.40
0.93
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
873
8513
1.14
0.93
3.7
3.7
mmol/l
1.3
1.3
1.48
861
7866
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
28
2.15
0.91
3.5
1.9
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
58
466
1.26
0.90
1.8
1.7
g/l
1.4
1.5
0.10
53
429
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
27
370
0.72
0.90
1.5
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
55
444
1.25
0.84
2.1
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
154
1.44
0.84
1.6
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
28
374
0.74
0.81
2.3
3.6
mmol/l
1.8
1.9
0.06
21
278
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
54
438
1.25
0.80
1.1
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
24
0.00
0.79
0.0
2.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
33
1.82
0.79
3.5
1.9
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
25
0.00
0.79
0.0
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
3.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
26
0.00
0.78
0.0
1.3
—
348.9
—
0
17
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
26
0.00
0.78
0.0
1.0
—
12.7
—
0
18
(21494755) Public health laboratory ask at order entry panel
116
1017
1.16
0.76
1.4
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
59
1.70
0.76
1.9
2.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
53
1.70
0.75
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
25
335
0.74
0.75
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
51
415
1.24
0.74
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
38
1.85
0.73
1.6
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
40
1.75
0.71
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
223
2417
0.90
0.69
1.3
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
127
1.42
0.68
1.1
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
91
0.55
0.67
1.2
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
92
0.54
0.67
1.2
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
65
554
1.18
0.62
2.1
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
28
217
1.30
0.62
1.1
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
456
0.80
0.62
1.6
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
19
139
1.37
0.60
1.8
1.4
u/ml
119.6
111.3
—
5
24
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
0.4
—
0
15
(3045788) Cell count panel - Pleural fluid
8
52
1.54
0.59
2.4
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
22
0.00
0.59
0.0
2.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
18
131
1.38
0.59
1.4
1.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
64
1.57
0.58
1.1
1.0
mg/l
296.9
290.1
—
10
57
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.5
—
185.5
—
0
12
(3042733) HLA Ab [Presence] in Serum
0
23
0.00
0.58
0.0
4.3
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
23
0.00
0.58
0.0
1.4
—
78.2
—
0
18
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
253
0.75
0.58
3.3
2.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
28
220
1.28
0.57
2.4
2.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
54
1.49
0.57
1.1
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
150
1641
0.90
0.57
1.4
1.4
g/l
2.1
2.3
0.52
114
1029
(3004616) Nuclear Ab [Presence] in Serum
5
88
0.57
0.56
1.2
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
89
0.56
0.56
1.2
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
89
0.56
0.56
1.2
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
90
0.55
0.55
1.2
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
148
0.67
0.55
1.3
1.3
—
—
—
0
0
(4062490)
9
62
1.46
0.53
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
98
0.61
0.52
1.0
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
145
0.69
0.51
3.0
2.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
119
1.35
0.48
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
68
1.48
0.47
4.5
4.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
82
0.61
0.46
1.2
2.5
pg
34.2
32.5
—
5
82
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
85
0.59
0.45
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
152
0.72
0.44
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
151
0.73
0.43
1.3
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
151
0.73
0.43
1.6
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
94
0.64
0.42
1.2
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
57
1.41
0.42
1.8
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
58
1.38
0.41
1.4
1.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
6.9
—
0.3
—
0
15
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
16
0.00
0.41
0.0
1.0
—
6.2
—
0
16
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
57
645
0.88
0.41
1.4
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
17
0.00
0.40
0.0
1.1
—
170.1
—
0
8
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
8
61
1.31
0.39
2.4
1.2
e6/l
1854.4
1710.5
—
8
40
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
25
205
1.22
0.39
2.0
3.8
—
1.1
—
0
15
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
12
159
0.75
0.38
2.7
2.7
mmol/l
1.1
1.6
3.87
12
153
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
6
42
1.43
0.35
1.0
1.1
—
2.3
—
0
7
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
7
52
1.35
0.31
1.3
1.0
ng/l
481.4
657.4
—
7
33
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
96
0.73
0.31
1.0
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
7
53
1.32
0.31
1.3
1.0
ng/l
278.3
335.6
—
7
34
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
7
53
1.32
0.31
1.3
1.0
ng/l
30.0
46.2
—
7
34
(3000093) Morphology [Interpretation] in Blood Narrative
7
55
1.27
0.30
1.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
336
3468
0.95
0.28
3.1
2.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
32
365
0.87
0.28
1.3
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
11
140
0.78
0.28
1.1
1.1
—
15.0
—
0
34
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
103
1.27
0.28
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
103
1.27
0.28
1.1
1.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
8
62
1.29
0.28
3.5
2.0
—
45.3
—
0
9
(3025130) Human papilloma virus identified in Specimen
17
140
1.22
0.27
1.3
1.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
8
65
1.23
0.27
2.1
1.3
g/l
29.3
33.4
—
8
59
(3027944) Amphetamines [Presence] in Urine
37
328
1.13
0.27
1.1
1.6
—
—
—
0
0
(4094501)
20
236
0.84
0.27
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
67
1.20
0.26
2.0
3.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
214
0.84
0.26
1.3
1.4
ug/g
214.2
305.2
—
10
123
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
77
830
0.92
0.26
4.1
4.3
ug/l
2.6
28.5
1.79
58
659
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
34
383
0.88
0.26
1.4
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
58
633
0.91
0.26
3.9
3.3
mmol/l
3.5
2.1
1.61
41
509
(3027008) Opiates [Presence] in Urine
37
330
1.13
0.25
1.1
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
105
1.24
0.25
1.2
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
50
455
1.10
0.24
2.3
2.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
21
180
1.17
0.24
1.0
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
83
776
1.08
0.23
2.3
4.3
u/l
237.2
246.1
0.34
75
744
(3028300) Cannabinoids [Presence] in Urine
37
332
1.12
0.23
1.1
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
38
1.32
0.23
1.4
1.1
miu/ml
2018.8
1863.7
—
5
38
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
93
0.75
0.22
1.1
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.2
—
139.4
—
0
6
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
2.5
—
0.9
—
0
10
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
10
0.00
0.21
0.0
2.7
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
5.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
4.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
323.8
—
0
5
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
102.7
—
0
12
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
13
0.00
0.21
0.0
1.2
—
3.0
—
0
13
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
13
0.00
0.21
0.0
2.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
13
0.00
0.21
0.0
5.8
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
12
144
0.83
0.20
4.4
2.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
29
322
0.90
0.19
1.9
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
53
1.13
0.18
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
121
0.82
0.18
2.3
3.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
42
387
1.09
0.17
1.1
1.1
—
66.5
—
0
11
(3028626) Oxygen [Partial pressure] in Capillary blood
12
142
0.84
0.17
3.5
2.9
kpa
8.3
8.1
0.13
12
134
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
163
0.86
0.17
1.4
1.6
—
—
—
0
0
(4024509)
7
62
1.13
0.17
1.4
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
49
456
1.08
0.17
1.2
1.2
—
49.9
—
0
24
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
108
1034
1.05
0.16
1.6
1.7
%
1.4
1.4
0.28
102
911
(21494890) Protein electrophoresis panel - 24 hour Urine
8
72
1.11
0.16
1.1
2.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
12
102
1.18
0.15
3.8
3.9
%
2.0
1.2
0.41
12
82
(3022145) Colonoscopy Study observation
95
909
1.05
0.15
1.2
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
27
246
1.10
0.14
4.2
3.8
g/l
0.2
0.3
—
6
98
(3003327) Ova and parasites identified in Stool by Light microscopy
23
252
0.91
0.12
1.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
190
1856
1.03
0.12
4.5
4.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
124
1.13
0.11
1.0
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
105
1.14
0.11
1.1
1.2
nmol/l
0.7
0.6
0.10
12
99
(3015235) Bicarbonate [Moles/volume] in Capillary blood
18
163
1.11
0.10
3.3
3.0
mmol/l
24.8
25.3
0.24
18
143
(3000764) Benzodiazepines [Presence] in Urine
35
329
1.07
0.10
1.1
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
28
261
1.07
0.10
1.3
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
32
301
1.07
0.09
1.1
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
280
2762
1.02
0.08
3.0
3.5
mmol/l
2.3
2.4
7.67
267
2446
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
62
0.81
0.08
2.2
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
64
0.78
0.08
1.2
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
66
1.06
0.08
1.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
15
164
0.91
0.08
2.7
2.2
ug/min
43.3
76.4
—
10
101
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
85
0.82
0.07
1.3
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
89
1.12
0.07
1.7
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
26
246
1.06
0.06
1.5
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
111
1.08
0.04
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
119
0.92
0.04
3.4
2.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
131
1.07
0.03
1.4
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
151
1494
1.01
0.03
1.7
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
209
0.96
0.03
1.2
2.7
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
13
122
1.07
0.02
1.3
1.2
u/l
61.7
23.7
0.40
13
105
(3043409) Potassium [Moles/volume] in Arterial blood
20
198
1.01
0.00
5.7
3.0
mmol/l
3.9
3.8
0.33
12
182
(1002224) Polysomnography panel
39
388
1.01
0.00
1.1
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
21
209
1.00
0.00
2.4
2.0
ug/l
449.4
473.6
0.03
21
196
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
241
1.00
0.00
1.8
1.9
iu/l
7.6
4.7
0.41
11
98
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
247
1.01
0.00
1.1
1.8
—
—
—
0
0
(4306422)
11
115
0.96
0.00
1.4
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
51
0.98
0.00
1.4
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
76.6
—
0
7
(3042517) Benzodiazepines panel - Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
96
0.94
0.00
2.1
2.5
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
37.5
—
0
5
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
8.4
—
0
5
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
50
1.00
0.00
1.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
8
81
0.99
0.00
2.1
2.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
0
7
0.00
0.00
0.0
2.1
—
15.4
—
0
7
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
14.3
—
0
5
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
24.1
—
0
8
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
13.3
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
88
0.91
0.00
1.9
2.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
9.0
—
0
6
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
82
0.98
0.00
2.0
2.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
0.1
—
0
6
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
171.4
—
0
5
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
21.2
—
0
5
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
272.2
—
0
5
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
5.4
—
—
—
0
0
(4212803)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
3.5
—
9.3
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SHORTACHILLES and mortality.

Females

Parameter HR [95% CI] p-value
M13_SHORTACHILLES 0.623 [0.5, 0.77] < 0.001
Birth year 0.991 [0.98, 1.0] 0.048

During the follow-up period (1.1.1998 — 31.12.2019), 124 out of 4439 females with M13_SHORTACHILLES died.

Males

Parameter HR [95% CI] p-value
M13_SHORTACHILLES 0.91 [0.7, 1.19] 0.488
Birth year 0.984 [0.97, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 90 out of 1773 males with M13_SHORTACHILLES died.

Mortality risk

Mortality risk for people of age

years, who have M13_SHORTACHILLES.

N-year risk Females Males
1 0.049% 0.151%
5 0.323% 0.933%
10 0.926% 2.262%
15 1.691% 4.5%
20 2.845% 7.592%

Relationships between endpoints

↥

Index endpoint: M13_SHORTACHILLES – Short Achilles tendon (acquired)

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data